53 results on '"Catanzaro M"'
Search Results
2. 734P Primary retroperitoneal germ-cell tumours (pR-GCT): Evaluation of treatment outcomes of an international collaboration (PRIMERE study-IGG05)
3. SC209 - Bilateral inguinal lymph-node dissection versus unilateral inguinal lymph-node dissection and contralateral dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penis
4. 799 - Compliance of prostate cancer patients on active surveillance to protocol criteria: The experience of a large mono-institutional population
5. SC315 - Renal tumor biopsy (RTB) in patients with cT1b-t4-m0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management.
6. SC235 - Perioperative outcomes of post chemotherapy laparoscopic retroperitoneal lymph node dissection in stage IIA-III non seminomatous germ-cell tumors
7. SC231 - Long term outcomes of initial observation in patients with CN0 low-risk penile squamous cell carcinoma: a single institution analysis
8. Millennials Self-Reported Diet Quality is Associated with Adherence to MyPlate Recommendations, Consumer Behavior, Food Security, and Mental Health
9. SC221 - Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: evaluation of safety and efficacy of open and laparoscopic procedures
10. SC226 - Dynamic sentinel node biopsy for clinical N0 squamous cell penile carcinoma: a large, contemporary analysis
11. SC225 - Determinants of inguinal lymph node involvement and predicted rates of inguinal nodal disease in clinical N0 penile squamous cell carcinoma patients
12. SC224 - Dynamic sentinel node biopsy versus observation in clinical N0 penile squamous cell carcinoma: a large tertiary national referral center experience
13. SC186 - Active surveillance for small renal masses: a prospective translational study update (NCT03804320)
14. PT384 - Regression-tree analysis for identifying the best candidates to neoadjuvant chemotherapy in patients with clinical node-positive penile squamous-cell carcinoma
15. P081 - Favourable and reliable PSA doubling time can improve confidence in reducing the number of repeat biopsy during active surveillance
16. 911 - Active surveillance for small renal masses ≤2cm: Results from an Italian multi-institutional prospective protocol
17. 491 - Predicting overall survival (OS) in patients (pts) with penile squamous cell carcinoma (PSCC) undergoing regional lymph node dissection (LND) ± multimodal therapy
18. Clinical Results for an Active Surveillance Cohort with Localized Prostate Cancer Receiving RT after Exiting Active Surveillance
19. 795 - Effect of number of computed tomography (CT) scans during follow-up (FUP) of patients with clinical stage I (CSI) seminoma: A trial-level meta-analysis
20. 540 - Active surveillance in prostate cancer patients: Predicting the chance of continuing AS after re-biopsy
21. 927TiP - Cabozantinib in patients with advanced penile squamous cell carcinoma (PSCC): the open-label, single-arm, single-center, phase 2, CaboPen trial
22. 718 - Dacomitinib (Daco) induction therapy for locally-advanced (LA) or metastatic penile squamous cell carcinoma (PSCC): An open label, single-arm, phase 2 study
23. 211 - PURE01: An open label, single-arm, phase 2 study of the anti-programmed death (PD)-1 monoclonal antibody (moAb) pembrolizumab for neoadjuvant therapy of muscle-invasive urothelial bladder carcinoma (miUBC)
24. 174 - Neoadjuvant sorafenib, gemcitabine, and cisplatin (SGC) for muscle-invasive urothelial bladder cancer (MIUBC): Final results and translational findings of an open-label, single-arm, phase 2 study
25. 1089 - Laparoscopic retroperitoneal lymph-node dissection (L-RPLND) is not only a staging procedure in stage I non-seminomatous germ-cell testicular tumors (NSGCTT): Mature data from a referral centre
26. P028 - A validation analysis confirming different predictors of upgrading and upsizing at 1-year repeat biopsy in low-risk prostate cancer patients on active surveillance
27. 840P - Dacomitinib as first-line treatment of locally-advanced (LA) or metastatic penile squamous cell carcinoma (PSCC): Interim analysis of an open-label, single-group, phase 2 trial
28. 824 PRIAS vs SAINT: Comparing two active surveillance protocols
29. 711 Dacomitinib (PF-0299804) in untreated patients (pts) with advanced or metastatic penile squamous cell carcinoma (PSCC): Early findings of an open-label, single-group, phase 2 trial
30. 597 Interim [18F] Fluorodeoxyglucose Positron Emission Tomography (PET) for early metabolic assessment of response to PEB chemotherapy for metastatic seminoma: Preliminary findings
31. 598 Clinical outcomes of Intermediate Risk metastatic Germ Cell Tumors (IRGCT): Results from a single-institution series
32. PO-0730: Urinary and erectile function in prostate cancer patients: radical radiotherapy vs active surveillance
33. P150 Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: A systematic review and meta-analysis of patient outcomes
34. 873TiP - A Phase 2 Study of Paclitaxel and Ifosfamide Plus Either Cisplatin or Carboplatin for Patients with Metastatic Non-Transitional Cell Carcinoma of the Bladder and the Urinary Tract
35. 857P - Interim [18F] Fluorodeoxyglucose Positron Emission Tomography (Pet) for Early Metabolic Assessment of Response to Peb Chemotherapy for Metastatic Seminoma: Preliminary Findings
36. 859P - Clinical Outcomes of Poor Prognosis Germ Cell Tumors (Gct): an Analysis of a Series from a Single Referral Center
37. 855P - Radiotherapy or Chemotherapy for Clinical Stage Iia and Iib Seminoma: a Systematic Review and Meta-Analysis of Patient Outcomes
38. 1119 Total number of positive nodes and positive node ratio may predict recurrence in early stage non-seminomatous germ-cell tumours (NSGCT) undergoing primary retroperitoneal lymph-node dissection (RPLND)
39. 1123 Activity of pazopanib in chemoresistant patients with germ cell tumours (GCT): Early findings of the open-label, single-group, phase 2 pazotest-01 trial
40. 1116 Is template laparoscopic retroperitoneal lymph-node disection (Lap-RPLND) an advisable option for adequately selected patients with a residual mass of non-seminomatous germ-cell testicular tumours (NSGCTT)?
41. 791 Phase 2 study of neoadjuvant sorafenib plus cisplatin and gemcitabine (S-CG) for patients with muscle-invasive transitional cell carcinoma of the bladder (MIBC): Results at the end of first stage (NCT01222676)
42. 120 The curative potential of lymphadenectomy after response to chemotherapy in patients with urothelial carcinoma presenting with regional or distant nodal metastases: Analysis of a series from a tertiary cancer centre
43. 57 Neo-adjuvant and adjuvant combination of a taxane plus cisplatin and 5-fluorouracil in patients undergoing lymph-node dissection for nodal metastases from squamous cell carcinoma (SCC) of the penis: Is there an indication for a recommendable use?
44. Multidimensional geriatric evaluation at initial treatment in urological neoplasia: A cooperative prospective study
45. 1057 Persistence of CD30 expression by embryonal carcinoma (EC) in the treatment time course. A retrospective series of multi-relapsing germ-cell tumors (GCT)
46. 1055 Modified cisplatin, etoposide and ifosfamide (PEI) salvage therapy for male germ-cell tumors (GCT). Long-term efficacy and safety outcomes
47. 398 Long-term oncological outcomes of partial penectomy in the treatment of penile cancer: A 30-year single-institutional experience
48. 397 Early results of the pilot study with the anti-Epidermal Growth-Factor Receptor (EGFR) monoclonal antibody Panitumumab in patients (pts) with multi-relapsed or refractory squamous cell carcinoma (SCC) of the penis
49. 388 The characteristics of inguinal lymph nodes may predict pelvic lymph nodes involvement in penile cancer: A single-institutional experience
50. 83 Long-term efficacy and safety outcomes of the modified (simplified) combination of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) as front-line therapy for unresectable or metastatic urothelial cancer (UC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.